发布求助
文献互助 智能选刊 最新文献

The Brown University Psychopharmacology Update最新文献

筛选
英文 中文
Psychedelics and psychosis: Quantifying the risk
The Brown University Psychopharmacology Update Pub Date : 2025-01-29 DOI: 10.1002/pu.31278
Lawrence H. Price M.D.
{"title":"Psychedelics and psychosis: Quantifying the risk","authors":"Lawrence H. Price M.D.","doi":"10.1002/pu.31278","DOIUrl":"https://doi.org/10.1002/pu.31278","url":null,"abstract":"<p>Just over a year ago, I somewhat reluctantly weighed in on the implications for psychiatry of the resurgent interest in psychedelic drugs (Price, 2024). In contrast to the “psychedelic era” of the 1960s and 1970s, this time public interest in these compounds has been accompanied by skillful politico-legal advocacy and systematic research. Both of those endeavors require high levels of funding, and both private philanthropic and for-profit pharmaceutical entities have, for better or worse, stepped in.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 3","pages":"7-8"},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143120851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Weight-loss drugs improve outcomes in patients with alcohol use disorder 减肥药物可改善酒精使用障碍患者的治疗效果
The Brown University Psychopharmacology Update Pub Date : 2025-01-29 DOI: 10.1002/pu.31274
{"title":"Weight-loss drugs improve outcomes in patients with alcohol use disorder","authors":"","doi":"10.1002/pu.31274","DOIUrl":"https://doi.org/10.1002/pu.31274","url":null,"abstract":"<p>Use of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide was associated with reduced risk of alcohol-related hospitalization in patients with alcohol use disorder (AUD), a cohort study has found. Both semaglutide and the GLP-1 receptor agonist liraglutide were associated with lower risk of hospitalization than use of medication treatments for AUD. Study results were published online Nov. 13, 2024, in <i>JAMA Psychiatry</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 3","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143120842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta-analysis suggests safety of methylphenidate, atomoxetine in pregnancy 荟萃分析表明哌醋甲酯和阿托西汀在妊娠期的安全性
The Brown University Psychopharmacology Update Pub Date : 2025-01-29 DOI: 10.1002/pu.31279
{"title":"Meta-analysis suggests safety of methylphenidate, atomoxetine in pregnancy","authors":"","doi":"10.1002/pu.31279","DOIUrl":"https://doi.org/10.1002/pu.31279","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 3","pages":"6"},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143120852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ED visit for psychedelic use confers increased risk of psychosis
The Brown University Psychopharmacology Update Pub Date : 2025-01-29 DOI: 10.1002/pu.31273
{"title":"ED visit for psychedelic use confers increased risk of psychosis","authors":"","doi":"10.1002/pu.31273","DOIUrl":"https://doi.org/10.1002/pu.31273","url":null,"abstract":"<p>Individuals who had an emergency department (ED) visit related to use of psychedelic drugs were at higher risk of developing a psychotic disorder than those in the general population, a retrospective cohort study has found. These individuals also were more likely to develop a schizophrenia spectrum disorder compared with those who had an ED visit involving alcohol or cannabis, the researchers reported. Study results were published online Nov. 13, 2024, in <i>JAMA Psychiatry</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 3","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143120847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No protective effect of omega-3s for youths at risk of psychosis
The Brown University Psychopharmacology Update Pub Date : 2025-01-29 DOI: 10.1002/pu.31277
{"title":"No protective effect of omega-3s for youths at risk of psychosis","authors":"","doi":"10.1002/pu.31277","DOIUrl":"https://doi.org/10.1002/pu.31277","url":null,"abstract":"<p>A placebo-controlled study has found that use of omega-3 fatty acids had no protective effect on transition to psychosis in high-risk young people aged 13 to 20. This is the third recent randomized controlled trial (RCT) that has failed to replicate results of a 12-week trial that found a lower transition rate to psychosis in young people receiving omega-3s.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 3","pages":"4"},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143120850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of trial confirms efficacy of esketamine nasal spray in TRD 试验分析证实艾司卡胺鼻腔喷雾剂对TRD有疗效
The Brown University Psychopharmacology Update Pub Date : 2025-01-29 DOI: 10.1002/pu.31276
{"title":"Analysis of trial confirms efficacy of esketamine nasal spray in TRD","authors":"","doi":"10.1002/pu.31276","DOIUrl":"https://doi.org/10.1002/pu.31276","url":null,"abstract":"<p>Several sensitivity analyses of a Phase 3b trial have demonstrated that esketamine nasal spray was consistently more efficacious than extended-release quetiapine in patients with treatment-resistant depression (TRD). The additional analyses of the ESCAPE-TRD trial used multiple thresholds for remission and relapse. Study results were published online Dec. 2, 2024, in <i>The British Journal of Psychiatry</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 3","pages":"3"},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143120849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trial finds fezolinetant efficacious for vasomotor symptoms in menopause
The Brown University Psychopharmacology Update Pub Date : 2025-01-29 DOI: 10.1002/pu.31282
{"title":"Trial finds fezolinetant efficacious for vasomotor symptoms in menopause","authors":"","doi":"10.1002/pu.31282","DOIUrl":"https://doi.org/10.1002/pu.31282","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 3","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143110313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Your Medication Information 您的用药信息
The Brown University Psychopharmacology Update Pub Date : 2025-01-29 DOI: 10.1002/pu.31283
{"title":"Your Medication Information","authors":"","doi":"10.1002/pu.31283","DOIUrl":"https://doi.org/10.1002/pu.31283","url":null,"abstract":"<p>Duloxetine (generic) — Cymbalta (brand)</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 3","pages":"9-10"},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143120841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta-analysis finds viloxazine effective for youths with ADHD 元分析发现维洛沙嗪对患有多动症的青少年有效
The Brown University Psychopharmacology Update Pub Date : 2025-01-29 DOI: 10.1002/pu.31281
{"title":"Meta-analysis finds viloxazine effective for youths with ADHD","authors":"","doi":"10.1002/pu.31281","DOIUrl":"https://doi.org/10.1002/pu.31281","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 3","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143120843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study finds zuranolone impairs simulated driving performance
The Brown University Psychopharmacology Update Pub Date : 2025-01-29 DOI: 10.1002/pu.31280
{"title":"Study finds zuranolone impairs simulated driving performance","authors":"","doi":"10.1002/pu.31280","DOIUrl":"https://doi.org/10.1002/pu.31280","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 3","pages":"6-8"},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143120449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信